Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Geoffrey Young, M.D.

Co-Author

This page shows the publications co-authored by Geoffrey Young and Patrick Wen.
Connection Strength

0.531
  1. Spin-echo echo-planar perfusion prior to chemoradiation is a strong independent predictor of progression-free and overall survival in newly diagnosed glioblastoma. J Neurooncol. 2014 Aug; 119(1):111-9.
    View in: PubMed
    Score: 0.149
  2. Longitudinal MRI evidence for decreased survival among periventricular glioblastoma. J Neurooncol. 2011 Aug; 104(1):261-9.
    View in: PubMed
    Score: 0.118
  3. Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys. 2010 Sep 01; 78(1):85-90.
    View in: PubMed
    Score: 0.111
  4. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology. 2008 Mar 04; 70(10):779-87.
    View in: PubMed
    Score: 0.097
  5. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 07; 108(3):491-8.
    View in: PubMed
    Score: 0.032
  6. Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide. J Neurooncol. 2007 Sep; 84(2):179-83.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.